The following is a summary of “Integrative epidemiology and immuno-transcriptomics uncover a risk and potential mechanism for cutaneous lymphoma unmasking or progression with dupilumab therapy,” ...
Get detailed information on Dupilumab, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...
Upadacitinib has higher rates of rapid, sustained efficacy for the treatment of atopic dermatitis across several body regions when compared with dupilumab, but upadacitinib also had a higher rate of ...
Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.
Phototherapy involves the use of ultraviolet light for the treatment of skin disease and many dermatologists have phototherapy units in their offices. With these units, ultraviolet light of ...
Objective: To describe incidence, titer, and persistence of dupilumab ADAs and NAbs, and their effects on pharmacokinetics, efficacy, and safety in patients with atopic dermatitis (AD). Methods: This ...
Intravascular large B-cell lymphoma is a rare type of non-Hodgkin’s lymphoma. Its symptoms can vary greatly, making it difficult to diagnose. This type of lymphoma is aggressive, and outlook for ...
The new PDUFA target date is April 18, 2025. The Food and Drug Administration (FDA) has accepted for review the resubmitted supplemental Biologics License Application (sBLA) for Dupixent ® (dupilumab) ...
These comorbidities may influence treatment outcomes, prompting this study to evaluate the impact of such conditions on the efficacy and safety of dupilumab in young children with moderate-to-severe ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In a study in JAMA Dermatology, dupilumab maintained clinical effectiveness out to 5 years for many patients with ...
Nov. 20, 2024 — A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave the way for new treatment ... New Study Links Air ...
In the healthy state, T cells are genetically programmed to survey and protect the body from infectious agents, environmental stressors, and malignancy. In the process of development and ...